This meeting is being recorded.
Ladies and gentlemen, on behalf of Kaptify Consulting Investor Relations team, I welcome you all to the Q3 and nine months FY 2026 post earnings conference call of Control Print Limited. Today, on the call from the management team, we have with us Mr. Shiva Kabra, Joint Managing Director, and Mr. Jaideep Barve, Chief Financial Officer. As a disclaimer, I would like to inform all of you that this call may contain forward-looking statements, which may involve risks and uncertainties. Also, a reminder that this call is being recorded. I would now request the management to brief us about the business and performance highlights for the period ended December 2025, the growth perspective and vision for the coming year, post which we will open the floor for Q&A. Over to the management team.
Yeah. Good afternoon, everybody. My name is Jaideep Barve, and I work as the Chief Financial Officer of Control Print Limited. Welcome you all to the earnings conference call for the third quarter of FY 25-26. At the outset, let me wish you a happy and prosperous 2026. We appreciate that you have taken out time from your busy schedule to attend this call. Mr. Shiva Kabra, the Joint Managing Director of Control Print Limited, also joins me on this call. For first-time joiners on the earnings call, more information about our company can be obtained by visiting our website. Just for information, the detailed presentation has already been put up on the website, as well as in the investor presentation notification on the call this conference.
So let me provide you some highlights of the performance of CPL on a consolidated—on a standalone basis for the third quarter of FY 2025-26. On a standalone basis, the total revenue till Q3 is approximately INR 322 crore, which is a good growth from approximately INR 280 crore till quarter three of FY 2024-25. Just for information, the total revenue for FY 2024-25, 2023-24, and 2022-23 was INR 395 crore, 347 crore, and 295 crore respectively. Regarding the operating revenue, this is INR 109 crore for the third quarter. Corresponding period of FY 2024-25, this was INR 94 crore. Coding and marking represents 92% of the business. There has been a steady growth in the coding and marking segment.
Pipes, food, healthcare, dairy, steel and metal, cable and wire continue to be our top-performing business verticals. We are market leaders in cement, plywood, sugar, and dairy. The business outlook remains bold for the track and trace division in FY 2025, 2026. We have developed new solutions, and acquisition of new customers has been another plus point. We are getting good traction in the co-packing activities in the packaging division. A pipeline is also being generated for new machines, laminates, and the co-packing. The Mask Lab has now been re-established into a safety division, along with masks, hard hats, arc flash suits, helmets, gloves, blankets, et cetera, were also sold this quarter. On a standalone basis, the cost of goods sold is around 41%, 42%, 43% of the operating revenues in Q3, Q2, and Q1 respectively.
Just for comparison, for the entire year of FY 2024-25, the COGS was approximately 42%. That said, we remain committed to optimize the procurement costs and also look closely into the economy, efficiency, and effectiveness of operations. This, we feel, can definitely lead to reduction in the operating costs, thereby increasing in the gross margin. Manufacturing costs are approximately 2% of the operating revenue. In the earlier periods, this was around 3%. Employee costs are 19%, 16%, 18% of the operating revenue in Q3, Q2, and Q1 of this year respectively. Depreciation is 4%, and this is in line with the previous periods. Other expenses are 14% of the operating revenue in the Q3. On an annual basis, this has remained steady at 13%-14% in the previous periods.
Overheads will also be closely tracked with an aim to increase the overall profitability of the company. The EBITDA growth is at 21% YOY. PBT, excluding the exceptional items, was at 35% YOY growth. The PAT growth was lower at 19% due to higher tax provision in this quarter. The way forward. We wish to consolidate the existing coding and marking business. We would like to increase the install base, provide more robust solutions. An increase in prices has already been implemented. We want to develop new solutions and capitalize the available market opportunities in the track and trace segment. Similarly, the packaging business, both in India and overseas, will be closely monitored, and our emphasis will be in towards increasing machine sales, co-packing, and the laminates. The overseas subsidiaries will definitely be continued to be monitored with focused growth targets.
We have already provided them business plans, and they've been asked for execution. I now leave the floor open for questions. We'll be happy to address them.
Thank you, sir. We'll now begin the question and answer session. All those who wish to ask a question, please use the option of raise hand. We'll wait for a moment till the question queue assembles. We'll take the first question from Mr. Saket Kapoor. Please go ahead.
Yeah. Namaskar, Jaideep ji. Namaskar, Shiva, sir, and thank you, Kaptify team, for hosting the call. I hope I'm audible?
Yeah, Saket. Yeah, Saket ji, we can hear you.
So Shiva sir, firstly, if you could just explain to, to us, all the investors, how have our foreign subsidiaries and their consolidated results performance, what factors have again led to these, these lower profits where on consolidation, and what is the roadmap ahead for you? I, I'll just come up with follow-up once you, you start answering.
Last time I said that, you know, we should have a lower loss in this quarter and almost like a break even in the Q4 in our foreign subs, mainly the Italian one. You know, Codeology and Markprint are, like, combined about break even, so it's not that important. And what's happened is that we had. You know, we've come up with a new model or a new machine, a new packaging machine in Italy. But okay, so what happened in the past, I'll explain it to you. It's a long story. The reason why, you know, a lot of these machines were sold in the past, and I think that the quality control and that, you know, getting from a 90% machine to a 100% machine takes a little bit of more effort.
So what happened is, we didn't want to make, repeat the same mistake, so we're, you know, using more of a Control Print style of quality control and working out here to make sure the product is extremely reliable and robust. Because if that doesn't happen, you know, the customer's not gonna have the confidence to take the production on it. So, we've not been able to execute orders, or like besides one machine or something, I think in the last quarter, or this, Q3 and Q2. So because of that, we have a little bit of a backlog. So, the numbers would have looked better if we were able to execute the orders and book the revenue, and then, of course, the profit. So, now we are almost, like, we're pretty much through the machine.
We've got that first one out, we've got the second one. So for the first time in Italy, I think they're making two machines, which are exactly the same. And if this happens, then hopefully we should start actually executing a few of the orders we have, like, you know, or rather all the orders we have, which will help, you know, make the numbers in Q4 and, and maybe, you know, Q1 of financial, you know, whatever this, 2026, 2027 better. So I'm expecting that. It's not like we're not on target, but there's some, you know, there were some execution issues, you know, where we, as a company, you know, I mean, obviously, for us, the technology is first, and then comes all the other aspects of it.
So as we do that, I think that, you know, we're gonna get a much better result going forward. So, like, I think the results are slightly worse than the reality. But, you know, like I said, it's not like we're not losing money, but we should have been losing less money than what we were. So I don't think we're too far off our guidance. I think I'd said something like EUR 1 million. Maybe it's more like EUR 1.5 million, but we're not, we should do better.
Sir, to just understand it, it is the lower absorption of cost, fixed cost, that has resulted in these lower profits on a consolidated level. And going ahead with the dispatch of the machinery, which is there in the order book and already ready to be dispatched, we will be seeing better operating numbers. This is a correct understanding, sir?
Yeah, that's correct. That's correct. So, I mean, I can also tell everyone, see, we have, like, about EUR 800,000 a year R&D cost in Italy. This is, like, the direct R&D, you know, people are just assigned for R&D only and something else, so there's also other expenses associated. So if we actually... You know, whatever R&D they're going to do is gonna benefit us globally because those same products are available for sale in India and Asia Pacific and, you know, maybe in the future, North America and other places. So I will say that it's also, you know, because we expense all R&D, we don't capitalize anything, because this is what we do in India. And, you know, I think Jaideep may be a better result.
So I do think that also, you know, and I don't want to make an excuse that it's an accounting style or anything, because we've followed this for a very long time. So I think. But it's also making the Italian performance look a bit worse because they're not apportioning the cost of their development to the other areas where the machines are being sold. So that's where the difference is. But the technology is benefiting Control Print worldwide, if you are, I don't know, worldwide, but all the costs are being apportioned to Italy, so it's also making them look a bit worse than what they are.
Thank you, sir.
Yeah, yeah. Join the queue for the follow-up.
Yeah.
Thank you.
Thank you.
Thank you.
Yes. I request all the participants to limit their questions to two per participant. We'll take the next question from Hrushikesh Bhise. Please go ahead.
Thanks for taking my question, and congratulations on good set of the top-line numbers. So, my question is to Mr. Shiva Kabra. We spoke in July, when you said that the gross margins were impacted due to, you know, the higher raw material cost in the packaging business. So, and at that time, you had said that you're doing some R&D, wherein you are trying to crack something, wherein which can help you in some cost saving, and that could lead to better gross margins. So now when we see the numbers, the gross margins have actually become better for the consolidated numbers, but then the EBITDA has actually gone down. So I just wanted to know, like, what exactly is the scenario over here?
Yeah. So to answer your question, the situation is as such, we're still working on the development of the single polymer recyclable material. It's now under final trials. That's also one reason the machines are being delayed, because the machine needs some modifications to work with this material. It doesn't work at the full speed, but it at least gives us an option of recyclability. So, as a result, you know, that is also, like I said, why V-Shapes machines are delayed. Now, we are purchasing the materials from elsewhere and selling it, reselling it as per the customer's requirement. And definitely when we manufacture the material, it'll be cheaper, but also we are more focused on the recyclable material. So the margins have not changed much in this meantime.
If anything, with the euro going up or something, I don't know exactly, something or the other, it might have slightly increased. Our prices would have slightly increased, but, you know, with a slight lag. So I don't know if... I don't know till now if there's any benefit of all of these things. I think it's gonna take another four months, because we have some pilot line that we are starting in Nalagarh, and which we will shift later. So-
Okay, so-
But the line itself will only be delivered in March, and probably by the time it's commissioned, it's gonna be like April, May. So it's more of a pilot line, but we'll still be taking some production out on it, and it'll be relatively cheap to operate. It's just a lower volume, but we're talking about our volume, it'll still work. The second question you had, one was the margins, and then you said something about the EBIT does not flow down to the EBITDA. So yes, there is a question that's there, and Jaideep and me are looking at it very closely because both the other expenses and the employee costs have increased sharply.
I know some part of the employee cost was something like gratuity and some provisions or something that has been made, which Jaideep will give you a better read on that. So that's some part of the salary cost. But even if I take that out, there is a salary, there's a significant employee benefits cost increase. And the second part is that the other expenses have also increased. So we are actually taking a look at both of them, you know, quite closely. Jaideep, I don't know if you've got that number somewhere in this presentation, but... So yeah, so the gross margin, okay, it sort of dipped to 58.1% from the previous. But I wouldn't give it too much importance right now.
What I think is that the most important thing is that both the cost increase, the other expenses, and the employee benefit expenses. Now I said, like I said, the some part of the employee benefit expenses was some sort of an increase in some sort of provisions, which Jaideep will tell you. And then, the bigger part of the cost is a major part of the cost is an increase in the employee benefit cost. So we need to really go deep into that, to be honest, to understand what's where all these things have happened from and how this came about. And then the other expenses also increased. So, on both of these things, you know, Jaideep is doing a deep dive, so he's...
Maybe, maybe Jaideep can answer that question better.
All right. That's what, quite helpful. Essentially, broadly, you're trying to say that at a gross margin level, the projects that we were, you know, trying to say, it's yet to be fruitful. It is gonna take, like, another four months to another, reflected into the gross margin, if I'm understanding it correctly.
Yeah, it will take four months to introduce the product, and then obviously once we introduce that, and our cost of manufacturing is significantly lower than obviously what we are importing from Europe is basically much higher than whatever we get from here. So, you know, it'll definitely make the margins better. But what's important is the volume of the business should increase, you know, in the meantime, for which the machines need to be placed and work perfectly. So I think that that's also. So both things are important. But yeah, the margins will improve in the packaging business as a result of manufacturing locally.
All right. Thank you so much.
Thank you.
That's very helpful.
Thank you, Hrushikesh. We'll take the next question from Vikram Hirawat. Please go ahead.
Hello, everyone. Good afternoon. My question is to you, Mr. Shiva. So this is more product related. I was wondering if laser printers pose any significant risk to the consumable business? Now, I'm aware that Control Print does manufacture laser printers, but they don't, from my assumption, they don't really have the same sort of recurring revenue from consumables, because once you supply that, there's no ink that goes into laser printers. And I'm aware that certain industries are, for example, the pipe industry is now using laser printers for marking, for marking solutions. Is laser printer a threat to the consumables business or to the inkjet printers?
Yeah. So if I can answer that question, you know, the lasers have been around for about two decades now, and I don't deny that, you know, at least what I've seen in the 1990s, or even in the late 1990s, they started, you know, especially in certain high-speed bottling lines and certain things. So they have some fundamental limitations, and I'm gonna go through this. So this is technical. So the first thing is they don't work on all materials, okay? The second thing is they don't give a contrast. So for a lot of people who want a branded type of print, they're not gonna get a contrast. And so like you said, when you print on a pipe, it won't give a contrast on it if it's an LLDPE drip or HDPE drip irrigation pipe.
What it'll do is like an engraved print, which doesn't work for most people's branding. The third issue with, for our own purpose in terms of the laser business, you know, it's a different model, because there are less people, so the cost is less, which is also less of a service thing, but there is also an AMC element to it, and the lasers have a life of about five years. So what you do is the frequency of replacement of the laser is more common, more frequent.
And there is, like, an IV in terms of, you know, maintaining the fume extractors and changing the filters of the laser and doing some other things. So there's not a direct consumable, it's more of a service type of a contract and a spares contract that, or the services and spares that you're selling. And then the life of the machine being a bit less, you keep replacing the machine every, you know, 4 or 5- I mean, of course, in the pharma industry and certain other things with the low usage, it might even be 7, 8 years. But fundamentally, in most companies, you replace, like, every 4-5 years. So from a earnings perspective, it's not that much different to us. But, yeah, there, there is an element in, in both things.
But the most important thing is that the lasers don't work on everything. There's a big safety issue with lasers. Specifically, when you mention pipes, you know, on all chlorinated compounds or halogenated compounds, you know, iodine, bromide, type compounds, chlorine, what will happen is the moment you use a laser on it, it will create a chemical reaction on the surface. So it will, for example, release chlorine gas, you know-
On the at that point of time. And the chlorine gas will attack someone's throat and eyes, and also convert into hydrochloric acid by reacting with the moisture in the air. So both things are very dangerous. Now, in India, so if you look at the laser, fundamentally, it's a Class 1A safety, you know, that's around it. It comes under some IEC rules. I've got all the technical details, but I'll have to, you know, explain it later. So the laser needs to be completely enclosed. It releases a whole bunch of small micron-sized fume particles when you print, so we capture them with the fume extractor, but still some are released.
Now, what happens is, like abroad, what we've seen is that the laser is growing, but it's not increasing because in a lot of lines, people find it a struggle to enclose the entire line, you know? So if I have a form, fill, seal machine or even a pipe machine, where the laser's there, it needs to be enclosed completely. It needs to be that if the safety is open, the entire line is interlocked, so the laser will switch off at the power level itself, and the line will stop, and so on. So in India, see, none of these things are being followed, even though we are also part of the same rules.
So I don't know what's gonna happen, but, you know, in general, like, you know, when we talk to the larger customers, yeah, and I agree that even they look at other people, so I'm not sure what's gonna happen in general. I will say that even the so-called big companies out here don't follow the same sort of safety norms that they will in their own home markets of,
Europe and, America or something. But, you know, I think they're more cognizant of these issues. So I think even as awareness grows, these things will happen. So in the pharmaceutical industry, again, you know, when they have a lot of particles out there. It's in a clean room environment, so they have issues sort of using lasers. So there are, you know, pluses and minuses in this whole situation. It's a very technical, you know, question of what you're asking. But fundamentally, what we are seeing abroad, you know, in Europe, in Japan, in America, and of course, also in India, that the Chinese guys are very aggressive in using laser for everything without any safety measures or any thought. But, elsewhere in the world, people are much more circumspect.
They're more, you know, cognizant of the safety issues and the technical issues. And the other thing with the laser, specifically on some materials, it will... Because of the thermal energy, it sort of engraves into the material. So when you have certain thin materials or where the barrier property is very critical, it'll also cause pinholes in that material. So, like I said, there are multiple issues. We are also in the packaging industry, and people are being forced to use more recycled material, even though nobody's doing it right now, but that's gonna happen. So what happens is the recycled materials behave differently than the virgin materials. So when you print on the recycled material, you might not get the same print quality. It might be much more uneven. So, you know, there are various pluses and minuses in this whole aspect.
But, you know, I think laser will keep increasing at a gradual rate. I think for us, in our business model, it's not really an issue. But I don't see, from your fundamental question, I guess it's been around for a long time, unless there's some method of overcoming, especially the safety issues and then the issues in terms of contrast on the material, you know, I don't see it ramping up very fast.
Just so, so to sum it up, you're saying that, I mean, like, this is not... For now, you don't really see a big threat to the fundamentals of the business. Well, and also there's some sort of industry risk or substrate risk, and you cannot really apply laser to every particular product, is what I'm trying to—is what I've understood.
Yeah. So, so the laser is restricted definitely to certain products where it's there. Like I said, certain people, specifically because you mentioned pipe, I've answered that.
I'm saying in certain places people can use the laser, but it has safety issues, so some people are still using the laser. So it's, you can use it on LLDP drip irrigation pipes, for example, but you can't really use it on any of the PVC, CPVC, UPVC, or any of the chlorinated pipes, you know?
So I'm just trying to say that there is a, you know, element to the whole thing. On a LLDPE drip irrigation or HDPE pipe, when you do it, you need a lot of energy to get a small engraved print. Now, for a lot of customers who want to brand their product, you know, the contrast, they want much more contrast and visibility. You get my point, because if it's just for internal traceability, that type of print is fine. But if you want-
Okay
That the customer should know that it's a Supreme pipe, for example, you know?
And see it, and you want a Dhakad logo or whatever, you know, then you need to have a high-contrast print on it, which you can't get with a laser. So what I'm saying is, there are multiple issues in the laser adoption, and therefore, the laser has picked up slowly. In China, it's picked up faster because in certain cases, a lot of cases, most cases, they are ignoring a lot of safety-related issues around the laser, or the safety regulations are already in place.
Okay.
And, you know, obviously, but it's still, even in China, the, you know, the coding market has not decreased, you know, per se. It's just maybe a higher percentage of lasers has happened, but it—the rest of the market, the, even including the CIJ market, is still growing or at least stable.
Okay. All right. I think that's it. You've answered my question. Thank you so much.
Thank you. We'll take the next question from Ansh Himawat. Please go ahead.
Hello. Thank you for taking my question, sir. So building on, on the previous participant's question, just trying to understand as to where was the delta and the gross margins and the employee cost. Can you just throw some color on that? Also, on the other expenses.
There is a lot of background noise coming from your end.
I'm sorry, can you hear me now?
There is background noise coming.
Just a moment. Yeah, Ajit, is it clear now? Hello.
Yeah, better now.
Okay. Yeah, hi. My question was regarding the decline in gross margins and the increase in employee costs and other expenses. Can you just throw some color on that as to where have we seen the delta over there, apart from the gratuity and the other provisions that we've made? Because there seems to be a considerable movement in the employee costs per se. So that would be my first question.
Gajit, please.
Yeah. Hi, I think I'll take this question, Ansh. So what happened is that, as you rightly said, the employee costs have risen in the Q3 as compared to the Q2, and that is basically mainly a reason of adjustment of provisions. So you are aware of the new labor code, which has been mandatorily applied. So since 21st of November, now we are under the new regime of the new labor code. So as per the mandate given, we have to absorb all the past service costs also. So we had a major impact because of the gratuity provision, and also we made some kind of staff incentive provision. So that's the result why, you know, like, the staff costs, the employee costs have risen.
Other expenses are on the higher side, but definitely we are looking at most more cost control measures. Like, basically, business promotion expenses or travel expenses have grown as compared to the past quarter. We would like to, you know, like, concentrate more on the, you know, like, control aspect. And, definitely, we are-- we'll try our best to, you know, like, get a reduction on this and optimize the costs. So in the Q4, we'll make sure, you know, the results are better in terms of the overheads as well.
But, sir, in your note file, you have said that there is no material impact on the new labor code. So there seems to be some kind of a mismatch over here, sir.
I'm not getting the last line, Ansh.
I'm sorry. I'm saying, sir, in your note number five, to notes to the accounts, you have mentioned that there is no material impact to because of the labor code. So just trying to understand as to then-
No, the-
The mismatch.
Which the material impact-
The INR 2 crores-
Yeah
It may be increasing in terms of the delta, but it's not a material impact on our overall results. Do you understand what I'm saying?
Okay.
If you're saying, like, the increase is... What I think is in your-- I don't know what the exact numbers are here, but I think that the employee costs increased by something. But, okay, so about INR 2 crore was the provisions, is my approximate idea. And-
Increased by INR 5 crores.
Which means part of the delta, like he said, but it doesn't explain the entire delta. That's, that's what I said before. But if, if, if you take out that amount, then, you know, the delta looks less. But it, it's not material in our overall results. I mean, we have to be honest about that.
Okay. And so my next question would be on the impact on the India-EU FTA. Where do we see ourselves placed because of this? And, do we see the foreign players being able to enter the market per se, and being able to take our share in the market? Can we get some color on that as well?
I can't hear you clearly. Can you please repeat this again?
I'm sorry. Is it better now?
A bit better now, yeah, please.
Yeah. I was just asking regarding the India-EU FTA, do we see any foreign players entering the market post this FTA? Do we see any kind of, movement coming from Europe in this space? Do we see any, like, anyone taking our market share, taking our business from us? Can you just throw some color on this?
It's absolutely of no consequence either way. It may make our exports a bit cheaper. I don't know actually what the duties were previously on stuff from India to there. The three main competitors, Videojet, Domino and Markem-Imaje, all manufacture in China primarily. And then Domino and MI have an assembly line right at the end for here, so they get the entire kit, and they get like a sort of CKD or a SKD or something, and they just assemble it here. But since none of the three manufacture in the Europe anyways to begin with, none of the imports are gonna come via Europe. So, I don't think that fundamentally anything changes.
And more importantly, in our business, like I said, it's a sticky business because most people have a printer, everyone is competitive, the service network needs to be there, everything else needs to be there.... and those are, I'd say, the most important critical factors for people to be successful in this business. So I don't think we are gonna benefit much. I don't think we're gonna in any way be impacted differently, negatively, we're not gonna be impacted negatively. I don't think it makes a difference to our three key competitors. Yeah, I don't see this being, I would say, not really having any bearing on this, of course.
Thank you, Harsh. All right. Thank you.
A one-year-long line, if it happened before, it could have helped a little bit in that the packaging machines and the packaging materials that we import from Europe would become a bit cheaper. But by the time I think this FTA is ratified, we'll already have our own production of the packaging materials. So I don't see it being useful in that aspect.
Okay, sir. That's helpful. Thank you. Thank you. We'll take the next question from Vineet Thakur. Please go ahead.
Hi, sir. Good afternoon. Thank you for the opportunity, sir. I actually wanted to know a couple of numbers. So what would be our segmental performance in volume, as sales volume? What would be the sales volume of printer and installed base for nine months?
Shiva, I can answer this question. The printer sales for the nine months are a little over 2,100 printers, and our installed base is about 22,000 plus printers.
Sir, what's our revenue breakup by region and by segments?
So, within the coding and marking, we have four different streams of revenue. So one is the printers, the other is the consumables, then the spares and the services. So the breakup for the Q3 is 18%, 58%, 7%, and 15%.
Oh, thank you, sir. Sir, what would be our opinion about the Europe operations? When can we see a reversion of EBITDA margins?
Yeah, sure. You want to take this question?
You just please repeat that question. I, I couldn't quite get it out of it.
I wanted some clarity, sir, since we were doing, at, you know, 24... Am I audible, sir?
Yes, yes.
We were doing 23, 25, and 24 in FY 2022 to 2024, and since Europe, we have fallen down to around 19%. What would be? When could we assume we could get back to the original margins, or we would stop bleeding money in Europe operations?
So I think, okay, I mean, I cannot say anything to everyone, but, like, if I look at it on a standalone basis, which is what is more important for us, now, even the standalone basis carries, like I said, the track and trace business is breakeven. It might even be making money, you know, depending on how we apportion the overheads, it's making money, or I'd say on a marginal basis, it's profitable now. The packaging business, even in India and Asia, is loss-making as of right now. And obviously, in Italy and stuff like that, we have a much bigger, you know, losses that we are taking on that account. Now, the three different businesses fundamentally, or four different businesses, one is the coding and marking. I put the digital printing in that.
That's like one business that is still growing. The profits are there, and the margins are consistent, and the profits have increased. Although we are still doing a breakup exactly of where the other expenses and the employee benefit expenses have increased. But we believe that the business has grown further in profit in line with the revenue, if not more. Okay? I don't want to give the exact breakup because you're not providing it in the presentation, but fundamentally, that business's gross margins and revenue are, there's revenue growth of, I don't know, like 14%-15%, something of that sort in the standalone business.
Some part of it has come from the packaging and the track and trace, which have grown faster but from a much lower base, and that business is, is, is a profitable business, and the margins are increasing because our costs are not increasing that fast. But we're doing an exact checkup because the other expenses is something that we are confused about because we've not looked at it in that depth. From the employee costs, I can say most of the employee costs, which have increased, have increased in the packaging business, maybe the track and trace business, and the other things, and especially the international business.
Now, as the packaging business, you know, ramps up in volume, like I said, we get past some of these technical niggling issues, which we believe we've resolved, and we are able to execute the orders in this quarter and the next quarter. It's a slightly lengthy process because even though the machine is now fixed, the customer still has to come to the factory, do a factory acceptance test, and all these other types of things, which is a bit of a different, longer, drawn-out process as compared to, you know, what we do in our coding and marking business. Where we just, it's like a ready-made product and we just ship it.
So my view is that, you know, as the packaging business moves up in terms of revenue, and I do believe that in Q3 or Q4 of this financial year, this coming financial year, even in Italy, it's gonna be breakeven. And in India, it'll be profitable, hopefully by Q1 or Q2 of next year, or Q1 of next year. So I think as that happens and the losses of the packaging business come down, the consolidated, even if we are not making money, the standalone and the consolidated will sort of merge, you know? So my feel, my gut feeling is that if we can make as much money in India in the packaging business as what they may lose in Italy in Q1 and Q2, at least we'll be sort of on a breakeven basis, on the overall thing.
and then you will see a sort of homogenization of the standalone and the consolidated, and then the margins across the board will be quite similar. And then, obviously, the longer term plan is that the packaging business will grow and will be profitable, in and of its own, and so will the track and trace business. I definitely expect them to contribute significantly to the bottom line, in the coming financial year. So if I looked at the business and I sort of X-rayed it, and I looked at different segments, then, you know, I think that the core coding and marking business is still, as profitable on a gross margin basis, surely. I can say that.
But I think even if although we've not done that deep dive and apportion the expenses perfectly between the businesses, but even if, from whatever I can see from the employee point of view and other direct costs which are measurable for us, it has grown in profitability. It has grown in, like in margin in percentage margin, in an EBIT basis, it, it has grown.
Thank you, sir. And one last question would be, sir, what is the-
Sorry. Sorry, may I request you to rejoin the queue, please?
Okay, we'll rejoin.
We'll take the next question from Shubham Jain. Please go ahead.
Hello, am I audible?
Yes, Shubham.
Sir, my question would be, if we are operating in an oligopoly market itself, and we have so much of unutilized capacity, why has our market share remained or capped at around 40, 20-odd%? Is it the barrier to taking share from Videojet or Domino a matter of technology, or is the, lock-in of consumables at the competitor side stronger than what we could have anticipated in the past?
So, Shubham,
Yes.
Can you hear me clearly?
Yes, sir.
Yeah. So, I mean, I think the answer, the question has been answered in many con calls. Fundamentally, it's a very sticky business, and we have actually grown our market share slowly over the last few years. But because it's a sticky business, you know, it's difficult for the competitor to take our customers and for us to take our competitors' customers. So it happens, but it's a bit of a slower business. But technology-wise, I think we've got the best product stack right now, definitely.
What could trigger a market share increase, let's say, hypothetically?
So, so definitely one of the gains we've had is more like, you know, in our non-CIJ products, and where, especially in the thermal inkjet and the piezo, where we've gained market share. So as technologies change, like, you know, some earlier person was talking about laser. So, you know, sometimes people are more open to using someone else's CIJ and then, you know, a second supplier's laser going forward or a second person's, you know, thermal transfer or thermal inkjet. So I think that's one area where we feel maybe there's some opportunity to gain market share. And the second is to, you know, just continuously perform a bit better and just keeping these small market share gains because they're very profitable.
So even though the market is growing at 10%, and we're growing at 14%, you know, that's, that's still quite profitable for us, you know. It's, because that extra 4%-5%, is... Yeah, it's a lot of money.
Right. So, and the second question would be, we are running some pilot projects with pharma cos, and, what is the typical gestation period from, let's say, pilot to getting a full-scale rollout? And what could be our potential, let's say, value addition in top line and bottom line, if you could, from that, if you could just give some-
So I cannot answer the top line and bottom line part because, you know, it's all hypothetical. But right now, the pilots are sort of over, but there's a lot of negotiation going on right now. Some contractual elements to the negotiation. It's not just a commercial negotiation. There's also legal aspects to it. So we are in the process of trying to finalize those deals.
Okay.
Uh, but-
Okay.
You know, it's one of those things that, you know, we have to go carefully because it's—this is not a regular type of a sale of product. This is, you know, a patented technology we are giving, and there are certain restrictions in, you know, what the customer expects us to do and what we can provide and so on. So, so I think that given that, you know, we have two of the top five or ten customers in India and in the previous thing, so we have—I think we are closing now to in a finalization stage, in a commercial negotiation stage. But, we are, we're trying to close that hopefully in this quarter.
Okay. Sir, lastly, what is the-
It'll be soon. It'll be soon. But like I said-
Thank you, sir.
There's a little bit of back and forth because both people have given it, you know, us and our customers have also given to their legal teams just to make sure. So when lawyers get involved, you know, everything slows down, and it costs a lot more money.
Okay. Okay. Thank you, sir. I'll join the queue.
Thank you. We'll take the next question from Nitin Grover. Please go ahead.
Yeah, good afternoon, sir. My question is for Mr. Jaideep Barve. I hope I'm audible.
Yeah, you are. You are.
Okay. Okay, thank you for that. So, first of all, congratulations for an impressive growth in the top line. Okay. You published the numbers, I'm sure you can throw some color on the significant increase that we are seeing in the employee cost. Okay, I think you did mention that some part of it relates to the change in the labor codes, and another is on account of the increase in the provision on the side of incentive, right? Just wanted to understand, what is the policy that you are following in terms of making a provision for incentive? Are you making an upfront provision for incentive before the sales happen?
And because of that, there's a mismatch. Because the increase is quite significant. When I look at the numbers, it is a 28% increase in employee cost over last year, and 22% over the previous quarter. And it is definitely impacting the overall profitability that we are seeing for Control Print for the third quarter. Okay. So, yeah. Thank you.
Yeah. So, Nitin, I would like to address your question this way. See, incentives are always a result, as of, you know, like a planned structure process. So we identify the employees who need to be incentivized. We also have sales incentives policies. We've got incentive policies for the service managers, plus we've got incentive schemes for the back office team. So as and when, I mean, for the people where the results can be quantified, like sales and services, I mean, everything is, you know, calculated. For the others, where it is more of a non-quantified basis, what we do is that based on our experience and based on the performance, we prepare a list, and we get it approved, and then the provision is made according to that.
Thank you for that. See, your overall employee cost is, like, 23% of sales. I'm looking at the consolidated numbers. Do we expect a similar percentage to continue as we move forward? Or-
See, we are, we are definitely looking at, you know, optimization of not just the employee costs, but we are also looking at optimization of even the cost of goods sold and the other overheads. So, definitely we'll see some kind of a good improvement in the periods to come.
Okay, fine. Thank you. Thank you, Mr. Nitin.
Thank you.
I appreciate it. Thank you.
Thank you. We'll take the next question from Prateek Jha. Please go ahead.
Yeah. Hi. So, sir, my question is, like, could you share some guidance on the printing core business? What kind of industry growth do you expect over, like, let's say, three to five years, and how do you see your company growing in that period? Also, if you could, like, give us some color on the Track and Trace business, how you see that evolving?
Yeah. So Prateek, to answer your questions, now specifically looking at the coding and marking business, it's going to grow at 10, 11%, 12%, and depending a little bit on the Indian economy, like, we, we're assuming that India is going to grow somewhere like 6%-7%, and then, you know, coding and marking must be, like, one and a half times that, and so on. And, we've been doing a bit faster than that. We feel that our product portfolio is better than the competitors, so we will continue growing at that. Right now, considering our lineup and everyone else's lineup, and our edges compared to everyone else's, for the next year or two, I think, you know, like... because I can't predict 5 years down the line, but I'm sure we'll grow at the market.
But maybe in the next year or two, if we still maintain our product edges in, you know, the thermal inkjet and the Piezo and certain other things, we may be able to grow at faster than the market, like about 15%, you know, growth rate, according to me, give or take, you know, a couple of % here or there. And obviously, if we, if we maintain that edge, which we feel we've got a strong, you know, organization, a strong everything, maybe we'll be able to maintain that 15-ish% growth rate for a longer period. But like I said, it's, it's gonna there is a technical element to it, although I know I said that it's very sticky, but, you know, it's also, there's a technical aspect to it also. You know, the product does matter.
The second part of the thing, was the question regarding the, track and trace business and how it's evolving. So I said, like I said, you know, it's already INR a few hundred crores, like Jekson, ACG, those types of people are there. We're coming with a slightly different strategy, and we're doing some more plain vanilla stuff right now. Now we've sort of finalized certain elements where we should be able to go for more high value-added business. And, you know, if for us, it's more of a fusion of the track and trace into, you know, something which is gonna give much more business intelligence to the customer, rather than just meeting a compliance requirement. Because anyway, we have to meet the compliance, but how can we sort of connect that to resolve some of the customer issues?
So, you know, first, let me, let me try to conclude those two contracts, you know. Let us try to conclude them and roll them out. They are pilots, the big pilots, like, the pilot has to be co-commercialized now. And, and if that happens, we'll be busy with that anyways for quite a lot of time, and, you know, and then we'll have to see what the market reaction is and whether what we believe we're providing the customer as a benefit and what the customer believes he's getting. If he's getting it, you know, the market is big, and if he's not actually, you know, the theoretical benefit versus the practical benefit is not there, then, you know, yeah, we'll still sell stuff, but then it might not grow at that same rate. So it's very difficult to say.
We're making our technology platform play in both the packaging business and the track and trace business and digital printing. So they're very different from the coding and marking business, you know, where it's a very established platform and everyone knows what they're getting.
Thank you, Shiv- Shiva. Just a small follow-up question.
So it's difficult to predict, is my point, because these are like, you know, they can, they can, you know, they can be a hockey stick type of growth, or they can just not take off, you know. It's very difficult-
Right. Right.
for us to predict.
Just a small follow-up question on track and trace. So as of now, the demand that you are seeing, is it purely from the compliance perspective, or you are also seeing companies doing it by themselves? The reason I'm asking is that I've seen a couple of organic players. They are putting QR codes on their products so that you can see that from where it's been, the exact factory it is coming from, and et cetera.
Yeah. So those are all, like, children's things. No, so the reason is the compliance. So there's a thing called L1, L2, L3, L4, L5, which means, you know, when L4 and L5, it, the information that you print is connected to that of the regulators, you know, and people down the line in the supply chain, and so on and so forth. So what, you know, if people are printing a little QR code on, you know, a thing, and it's leading to a website link, that's just basically like a little bit of marketing-type stuff, that they want people to go onto the website and claim 10% and get his information or something. But no, what the pharmaceutical companies are regulated, or the top 300 brands or something of the sort, it's regulated.
For these customers, it's a regulatory and a compliance matter, so they don't have any. So they have to, you know, comply with the norms. And even in the export segments, in some countries, there is a requirement of this. So fundamentally, like, you know, it's a compliance-based business. And then we are trying, which is our strategy, that if you're doing the compliance, and we're getting so much data, and we're printing so much data, why can't we do more things on top of that and really resolve some of your burning issues? So that's what our fundamental take is, but it's a compliance-based business in pharmaceutical. Other people are doing it. Those are, like, not they're not mission-critical applications, I'll put it that way.
Thank you, sir. We'll take the next question from Trushank Jani. Please go ahead.
Yeah, hi. Thanks for the opportunity. Sir, earlier you mentioned that you've taken a price hike on our printers. So, are we the only ones who have taken a price hike, or our competition has also taken a price hike? And whether these price hikes are to match the commodity inflation or should this price hike result in any sort of gross margin expansion?
I think, Jaideep, you can take that one. But it is more not on the printer so much as the materials or the consumables and the services, and it was just lagging from our side. We had... There has been some cost increases, my belief, but I think Jaideep could, you know, answer this better. Jaideep? I think maybe he's gone off the call.
Sure. I'll ask my next question.
Sorry.
I recently met a company who had a packaging solution similar to V-Shapes, but it was not V-Shapes, it was some Chinese supplier.
Yeah.
I wanted to know if you are aware of any such Chinese competition there in the market, and how does our patent protect us against such competition?
Yeah. So the patent protection is quite fundamental. There are two companies that are there in this business. One is Easysnap, which was founded by the person who founded V-Shapes, and that uses an older patent. Now, that patent itself is being violated by the Chinese companies. And they do have a patent in China, but someone needs to go to China and sue those people and so on. And, you know, it's not easy to do that with a small Chinese company, because the guy will shut it, and his brother or sister will open a new company or something. So we'll have to go after the customers or something of that sort. But we don't have any, to be honest, real presence in China, so we don't know how to get all this stuff done.
But we do have patents in other countries, and, you know, we are not afraid to take legal options. So if a large customer out here employs one of those machines, we are not afraid to go to court. Now, the Easysnap patent will expire-
In terms of those printers versus, and as well as the per unit price, how would that match with us?
Let me just finish this thing on the packaging machine. Now, if the Easysnap patent will expire at the end of the year, so the Chinese people will be able to copy that type of machine. It has fundamentally some limitations, which is the reason we purchased V-Shapes, because we figured out that this technology is gonna have a benefit. And we have a patent till 2036 in all major jurisdictions. We've also filed a whole bunch of patent extensions and, you know, different types of patents to cover, like, you know, packing powders in our format or using the single, homopolymer , you know, like a homo polymer recyclable material, for example, or switching to a paper-based material, which is more than 70%.
So we've also been filing a bunch of other, or working on a bunch of other projects. So we expect that with an ecosystem of IP, you know, things around this, you know, it will make it difficult for people to get into the business because you cannot service all the needs of the customers, and so on. So, right now, now the Chinese guys who are selling are fundamentally, as of right now, out of patent of the Easysnap. People are not copying the V-Shapes machine as of yet. It's more complex, much more complex to make. They will copy it. Whenever they do, we will sue them, you know, that's as simple as it is.
Okay. And currently, the V-Shapes, the Easysnap technology, which is there, how is it competitive in terms of pricing-wise, say, per unit sachet and the printer, the packaging machine itself versus our solution?
They're very similarly priced. The main difference is that Easysnap is running on an older technology, so the speeds are much lower.
And also because the way they cut the material without a shape, it's much more difficult to do that consistently, so the material tolerances have to be much lower. And if the material tolerances aren't perfect and the setting of the machine is not perfect, then the chance of, you know, you making too deep a cut and the material leaking, or you're making too shallow a cut and the, you know, product not snapping, increases quite disproportionately. So yeah, Easysnap is not the main issue out here. The main issue right now is for us to just grow the market. It's not a sort of competitive situation, it's, it's more of, you know, I, I think all customers know that our, our product is not superior.
Okay. Understood. Thanks again. Thank you.
Thank you, sir. We'll take the next question from Samarth Singh. Please go ahead.
Yeah, thank you for the opportunity. Just a question on our cash flows, assuming our packaging business breaks even, and we are doing about INR 50 crore of cash flow a year, how much of that will go into CapEx to maintain the 15% growth in the coding and marking business? How are you thinking of the balance and plans to utilize the same?
So I think, you know, approximately what we depreciate, we spend about that much as maintenance and other types of CapEx. We don't even spend that much, but part of the depreciation is also certain things that we've invested, certain tooling, certain other things that we do. So I don't think that fundamentally the CapEx is required. There is some CapEx that we are doing in terms of the development of the homopolymer for the packaging material and, you know, its manufacturing and certain other things. But, you know, we don't expect either. We don't expect for our coding and marking, digital printing, track and trace business, there's no CapEx needed, you know. The capital investment out here is the R&D, frankly speaking, you know, and whatever projects we do on those fronts.
So, but the R&D-
The cash flow is probably higher than INR 50 crore, but I'm not sure what it is. Jaideep will give a better number. But yeah, I think we continue to maintain that, I think. Yeah.
So Shiva, the R&D is expensed or is it capitalized? That's the first one. And the INR 50 crore was from the presentation that you have posted for this quarterly results, so I got that number from there.
Yeah. So it might be in a consolidated basis. I think our, our standalone profits are high, and what's happening is some of that money is going into funding the, the losses and the other things of our subsidiary. But, you know, Jaideep will... Jaideep, Jaideep, are you here?
Yeah, I am there. I'm there.
Yeah. So if you can just answer this question about the cash-
So, uh-
-cash flows.
So, Samarth, what happens is that R&D costs are expensed out in the books of accounts.
Okay.
Yeah.
Okay, so we expense it.
But other expenses in the BSE filing will come under other expenses. Is this correct, Jaideep?
Yeah, and, regarding your question on whether any capital expenditure is required for the core coding and marking, I mean, there's nothing major as planned for the core coding and marking, which Shiva has also mentioned, because we are at the moment running at about 65%-70% of our capacity, so we don't foresee anything like, you know, a major CapEx in the coding and marking.
So, just to understand, out of the INR 50 crore or INR 60 crore of cash flow, we are paying about a dividend of INR 15 crore a year. What is the plan for the balance? Are we looking at more acquisitions or are we-
It's very early to say whether we are looking for acquisitions, but, I mean, if we come across, we might consider, I mean.
Okay, thanks. And the second question was just on, you know, our expansion into the Middle East. Who are the competitors there right now?
So if I may answer that question, fundamentally, you know, this, this expansion in the Middle East is not really. It's a small type of a setup that we're doing. It's not a major setup. So it's just meant to help service the customers that we already have, you know, in certain segments where we're very strong. So for example, you know, it could be in stuff like steel or something. So it's we only have, like, about four or five people working for that entire market, and it's meant more to be in certain niche industries and applications where we have some, you know, like, definitive technological advantages compared to our competitors, and to sort of replicate the same across the Middle East and Africa. So it's not like a heavy duty.
We're not gonna have, like, even 20 people there, we will, like, we have, like, 4, 5, 5 people, I think, assigned to that area.
Got you. Thank you so much.
Thank you. We'll take the next question from Nikunj Bhanushali. Please go ahead.
Hi. Am I audible?
Yeah, Nikunj.
Yeah.
Thank you for the opportunity. So, I just wanted to understand, how are we standing today on the packaging business? So I think we have established a machine in India, and we are trying to seed the market. So what sort of response are we getting from our customers, and what is the market telling us right now?
Could you just repeat that again? I'm sorry.
So for the packaging business, the V-Shapes business, right? We have established it in India as well, to seed the market, right? We have put up a machine, and we are doing co-packing for our customers. Is that right?
That's correct.
Yeah. So, so what are we hearing right now from the market? What are our customers telling us, and how is the traction there? And, are we seeing any demand and any growth there?
Yeah, so I think what happened was there is demand. We have 4 machines installed in India also, if. Yeah, if. But all of them are not working completely because of some niggling issues. So what's happened is we've as we got more into the business, we found out more issues because, you know, what's happening is people want to take, like, 100,000 packs to test the market and see how the format is, and to test everything. Now, what happens in that given situation is that they have a lot of technical issues because we struggle to print that much in such small quantities and certain other things. So as a result of this whole thing, you know, it's been a bit strange, but the market is good. It's actually quite positive.
You know, I have no problems with the way the market is shaping up, and it's definitely picked up in the last couple of quarters. Now we're really working on trying to execute the orders that we have, especially for the co-packing, and get the guys who bought the machine streamlined so that, because even they have the same thing that a lot of, you know, like, those guys are exporting, but then the customers they have are not taking one product and continuously running it. They have a range of different serums and face creams, and I don't know, whatever stuff that they use. And it's a bit painful because we need to, fundamentally, like, provide for all of those different situations.
So to print it, to test each material, test the compatibility, do the stuff, you know, whether you, you make a billion or you make, like, 10 pieces, yeah, it's still the same amount of work for us. So, to get the artwork to qualify that. So we, we've been working a lot on streamlining the process. We especially had a lot of problems in printing smaller batches and our turnaround times, because it takes 3 months for us to get something reversed and then laminated and sent back. And, you know, most customers want everything in 30 seconds, you know? So-
Right.
So we've been working a lot on streamlining our own supply chain because getting the machine, installing the stuff, getting the licenses, all those things was one part, but you know, we were not so equipped maybe to get those quick turnarounds for a lot of customers.
Right. And you mentioned-
But the demand is indefinitely increasing both here and in Italy. So I think, you know, now that things are much more streamlined, even our own team has a lot more confidence that we can execute the co-packing orders, and as a result, they are much more comfortable in taking a lot more orders. So yeah, that's what the thing is.
Right. You mentioned-
Thank you.
Four machines we have established, right?
Can you say that again, please? Can you say that again?
In India, we have sold four machines, right? Is that what you said?
Yes.
Okay. And, just in case of our acquisitions, how are each one of them doing? If you could share some numbers, like Codeology and Markprint. What are their nine-month numbers?
Deep, if you can help out with this, please.
Yeah, so, the nine-month numbers for Codeology is, like, it's... They're, they're picking up the business, in fact, but there's still, you know, like, something to catch up. So for Codeology, I mean, the entire consolidated Codeology group, we are having a loss of about GBP 147,000 as of now-- sorry, pounds as of now. And, for Markprint, I mean, it's a good position, though not a great position. Markprint generates profits, so we are not overly worried about that. However, the scale of business can definitely be improved, for Markprint.
Right. So majority of the losses-
Thank you.
is coming from the V-Shapes, right? The right Italy business.
The major losses are coming from Italy. You're right.
Okay. Okay.
Correct.
That, that's it from my side. Yeah. Thank you.
Thank you. Thank you, Nikunj. Sir, due to time limitations, that was the last question. Would you like to give any closing comments?
I think we can take the rest of the questions if it's there. It's no problem.
Okay. We'll take the next question from Moksh Ranka.
Hello, sir. I just wanted to ask about your international-
Sorry. So we'll see, because, I mean, obviously, someone is waiting, wants to ask a question. It would not be fair to not let them ask questions, so sorry about that. Please continue, Moksh. Sorry.
Yeah, I just wanted to ask about our international subsidiaries. Like, when is the turnaround expected for all our subsidiaries? And, could you provide some more color as to the current operations and any other timeline for the turnaround there?
Yeah. So Moksh, like I said, Codeology is profitable in their current business. Not massively so, not mainly so. They're just, like, a bit profitable because the UK market has been a bit down. The losses they're making are marginal. It's mainly because they are also... We have asked them to invest in the V-Shapes business, and we are establishing a co-packing and a full marketing setup in the UK also, and that's why they're taking some expenses for licenses, for other things, and whatever to start off. The Markprint business is already profitable, and we expect it not only to remain profitable, but to grow in profitability, and we're working on that. You know, so we've got some great applications there, some good stuff that we're working with them.
Now, the Italy business is fundamentally what we're all talking about because that's the major loss-making entity. You know, so, so I mean, Codeology, Markprint is not really that relevant in terms of the overall factor. The Italian business is the main one, and I'm expecting in Q3 and Q4 of financial year 2026, 2027, they will be breakeven. And I'm expecting that Indian business in packaging will be breakeven or profit. Breakeven, at least in Q1 and Q2, and profitable by Q3 and Q4. And so hopefully, I'm hoping that next year the packaging business as a whole will be breakeven, you know, if I combine it across India and, Italy and, and even the UK and so on.... Does that answer your question?
Yeah, yeah, that's it from my side. Thank you for answering my question.
Thank you, Moksh. We'll take the next question from Madhur Rathi. Please go ahead.
So thank you for the opportunity. Sir, I wanted to understand regarding the solution that we are offering in track and trace, and how is it different from ACG and the other players? Because I understand, sir, none of these players manufacture printers as we do. So if you could just help us understand how is our strategy different, and can we do a partnership with the likes of ACG, who do packaging and all, by supplying our solutions to them?
That's a very good question. Our solution is quite different to what they're doing. Like I said, everyone is doing the compliance. The big players in that are ACG, Jekson, and PharmaSecure, and Optel, which is more of an international player. And we are also one of those guys who has the entire solution from L1 to L5, and we get the entire compliance done. The difference between us and the other players is that we are focused more on, meeting the compliance needs like them, but also using our printing capabilities, our software capabilities, and other stuff to offer a more comprehensive solution to those pharmaceutical customers, so they can tackle other business issues of theirs. Now, I can't tell you exactly what it is.
Like I said, if we finish this negotiation, and we roll out the pilot, and I get a permission from the customers, I will make a presentation on this. Like, we make a white paper and a presentation, which we'll provide to everyone, next time, maybe, whatever it is. So let me, let me just finish this thing. You know, hopefully we... I will include everything and, we move ahead. Yeah.
Got it. And sir, second question was, recently there was a publication that your seed companies need to have a barcode, and they need to have traceability on their packaging. So can that be an additional market for our track and trace solution, along with our printing solution, the printers and the consumables that we provide?
Definitely agrochemicals, including, like, pesticides, and, you know, and, seeds, and also, I believe to some extent, fertilizers in the future are also gonna come under this regulation. But from what I might know, is like, I don't know if it's been. It, it's been notified, but not like, you know, it's been delayed or something has happened. So if you're saying it's, it's, official now, so people have started doing it, especially in the agrochemical industry for the pesticides. But I don't know if everyone is already executing. Obviously, if that happens, then the addressable market increases. But normally, in our past experience, till the government doesn't mandate it and say you have to do it, you know, it's a different business still.
And so, yeah, I don't know, from what my knowledge is, that the government has not mandated as yet.
Got it.
It's something that is supposed to happen, but delayed once or twice, and until they don't say, like, "You know, we're gonna pull your product from the shelf.
Got it.
Past experience shows that, you know, people don't really... But yeah, it will increase the ex addressable market for sure.
Got it. Sir, just a final question from me. Sir, how do we plan to scale up these label applicators and the barcode scanners that Codeology produces in India? Because I suppose that there will be a lot of customer synergy, product synergy versus the printing solutions that we are providing.
In fact, I'm in the Nalagarh factory right now, and the Codeology team is here, and they've come specifically to give the training on the entire print and apply manufacturing and setup. So, it was a bit delayed, but now we expect to really go ahead and, and move on it. So they will keep... You know, because you do it, you have some issues, and now, you know, now we're ready for the second round of real training and manufacturing out here. So hopefully after this, we'll be in a much better position to actually execute and, and, you know, start selling the solution to customers, rather than being a hypothetical tool in the market.
Got it. Sir, that was from my end, sir. Thank you so much, and all the best.
Thank you. We'll take the next question from Rahul K. Please go ahead.
Hello. Yeah, thanks for the opportunity. Yeah. Yeah, just a few questions from my side. So for the first one is, like, I would like to understand on the standalone basis, right? This time, our EBITDA is lower compared to last time. Is it due to the product mix or something else? Because, yeah, our revenue is also, like, higher from last quarter. Yeah, that is my first question.
So, Rahul, that's been addressed earlier in this conference call, but... Oh, and you could talk. Yes, Jaideep , if you want to repeat the thing again. N
See, actually, Rahul, I mean, as we've been saying, there has been an increase in the costs related to employee benefit expenses as well as other expenses. We've explained the reasons why they are, and management is definitely committed to, you know, take a closer look and monitor them, and we hope for a better Q4 in terms of the margins achieved through optimization of the costs.
Okay, sorry, I joined a bit late. Sorry, sorry if I have repeated the question. The second question is on the V-Shapes, right? So I think last con call also I attended, like, we were expecting somewhere around Q4 to break even on V-Shapes, if I'm not wrong, that was... So like, now it is delayed. Sorry if you have already addressed it, but if I can recollect, yeah, that was what was said in the last call.
Yeah. So we said earlier that what happened was, you know, we had some slight technical issues in terms of, you know, being able to send out the machines because we wanted to, like I said, some minor improvements we needed to make—we made on the machine. And therefore, we couldn't really ship that many machines in Q2 and Q3. We've shipped one machine, I believe, finally. And in this quarter and next quarter, we should be able to ship the remaining machines that we had, like a few machines, like, not a huge backlog, but we have a few machines that we need to ship out. That will reduce the losses in Q4 and Q1, or, you know, help us do it. So that will definitely help improve the overall performance.
At the same time, we're also getting a strong push in the co-packing business. I wouldn't say it's particularly profitable. It's more to, you know, help popularize the product and scale people up so that they start becoming, you know, machine customers and, or, or do the co-packing elsewhere with our, our package and so on. So I think from that perspective, it's, it's looking positive, you know? Yeah, I've given a specific guidance that in Q1 and Q2 in India, we'll be breakeven in the packaging business and profitable by Q3 and Q4. In Q3 and Q4 of this coming year, I expect that Italy to be breakeven. So there'll be losses, but they'll be on a declining platform from now on.
Okay. And one last question. Like, do we maintain the current, like, mid-teen growth, what, you, like, projected, in the earlier calls? So we, we maintain that guidance.
Can you repeat that again, please?
So I was saying, like, we projected mid-teens growth, right? In the previous con call. So do we like, project... Do we stand on that projection, right? Or do we have certain-
Right now, I think we've got the nine-month figures and so on. Jaideep, I don't know, but we, like, some 16% growth or something like that.
Yeah.
Something like that.
16% growth. Correct.
Yeah. So, yeah, hopefully we'll continue on a standalone basis in that zone or something. So, yeah, I mean, for three quarters... And obviously, like, you know, like I said, if the coding and marking market is growing at a certain pace, and then, hopefully we'll be able to grow faster than that. So, so probably maintain that for this year, for nine months. And, of course, for next year, we'll definitely see for next year.
Thank you, sir.
Okay. Thank you.
Thank you. Sir, since that was the last question, would you like to give any closing comments?
Just want to thank everyone for participating, and really appreciate your time. Obviously, I think a lot of questions regarding the gap between the standalone and the consolidated, and then because of some tax reasons, the PAT looks a bit poor. But, we're quite convinced that the standalone and the consolidated will start merging in this coming financial year.
Yeah. Thank you so much, everybody. It was nice to have you on the call, and keep supporting us.
Thank you. Thank you to the management team, and thank you to all the participants for joining on this call. This brings us to the end of this conference call. Thank you.